USA to promote IT in health care in Asia

9 August 2001

The US Trade and Development Agency estimates that developing countriesin Asia will spend over $6 billion on health care technology over the next five years and, to help US companies learn about new business in the region, the TDA will host a regional conference in Bangkok, Thailand, on October 17-19.

The conference is entitled Health care in Asia: new technologies, new options, and will be co-sponsored by the US Department of Commerce. Participating countries will include Bangladesh, China, Hong Kong, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Thailand and Vietnam.

The TDA will identify approximately 25 large-scale health care technology products currently on the drawing boards in the region, and representatives of each project will discuss their needs and meet interested US technology vendors.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight